Abstract

ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient

Author(s): Moon Richard B

Issue: Mar/Apr 2006 - Hospice/Palliative Care

Page(s): 95-98

Download in electronic PDF format for $75

Abstract

Hospice patients at the end stages of life often suffer nausea and vomiting, distressing symptoms that are either side effects of medications or direct effects of the underlying disease state. Such symptoms can greatly diminish the hospice patient’s quality of life. Effective pharmacotherapy is available, but in many cases traditional dosage forms are incompatible with the patient’s physical condition, cause discomfort, or are difficult for family members to administer. In such cases, a compounded preparation containing lorazepam, diphenhydramine, haloperidol, and metoclopramide—commonly referred to as ABHR gel—has proven highly effective. A number of case reports are presented to illustrate the effectiveness of ABHR gel in relieving the symptoms of nausea and vomiting in hospice patients. Also discussed are the causes of vomiting and the mechanisms of each of the medications contained in the ABHR gel.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Mar/Apr 2006 Pg. 95-98	ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient Author(s): Moon Richard B
Jul/Aug 2000 Pg. 250-251	Nausea and Vomiting in Hospice Patients Author(s): Boomsma Diane
Mar/Apr 2020 Pg. 168-175	Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel Author(s): Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
May/Jun 2014 Pg. 190-200	Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice Author(s): McNulty John P, Muller George
Jul/Aug 2006 Pg. 288-290	Hospice Symptom Relief Kit: An Update Author(s): Petrin Ronald L
Mar/Apr 2003 Pg. 106-113	Veterinary Transdermal Medications: A to Z Author(s): Davidson Gigi S
Mar/Apr 2006 Pg. 147-153	Initial Selection of Antiemetics in End-of-Life Care: A Retrospective Analysis Author(s): Tolen Laura, McMath Jill A, Alt Calvin, Weschules Douglas J, Knowlton Calvin H, McPherson Mary Lynn
May/Jun 2003 Pg. 183	ABHR in PLO (Lorazepam, Diphenhydramine HCl, Haloperidol, Metoclopramide HCl) Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 113-123	Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities Author(s): Zur Eyal
Mar/Apr 2006 Pg. 89-93	Hospice from a Compounding Pharmacist's Perspective Author(s): Jones Marty
Jan/Feb 2008 Pg. 28-37	Hospice and Compounding Pharmacy: Once Inseperable Author(s): Williams LaVonn A
May/Jun 2009 Pg. 220-221	Promethazine 25 mg/mL in Pluronic Lecithin Organogel for Nausea and Vomiting in a Pediatric Patient: A Case Report Author(s): Muller George
Mar/Apr 1998 Pg. 116-117	The Symptom Relief Kit for Hospice Patients Author(s): Petrin Ronald L
Jul/Aug 2024 Pg. 278-281	Ketamine for Pain in Hospice Patients - A Transdermal Gel Applied to the Painful Site Author(s): Wood Robert M
Jul/Aug 2000 Pg. 255-256	Custom-Making Medications for the Hospice Patient Author(s): Horwitz Robert
Jul/Aug 2000 Pg. 297	Dexamethasone 1.2%, Lorazepam 0.1%, Haloperidol 0.1%, Diphenhydramine HCl 2.4% and Metoclopramide HCl 2.4% in PLO Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 504	Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 247-253	Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel Author(s): Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
Jul/Aug 2000 Pg. 253-254	Ketamine for Pain in Hospice Patients Author(s): Wood Robert M
Jul/Aug 2000 Pg. 246-249	Hospice and the Role of the Compounding Pharmacist Author(s): Carling Maureen A